| Year |
Citation |
Score |
| 2018 |
Aranda F, Chaba K, Bloy N, Garcia P, Bordenave C, Martins I, Stoll G, Tesniere A, Kroemer G, Senovilla L. Immune effectors responsible for the elimination of hyperploid cancer cells. Oncoimmunology. 7: e1463947. PMID 30221060 DOI: 10.1080/2162402X.2018.1463947 |
0.497 |
|
| 2012 |
Vacchelli E, Galluzzi L, Rousseau V, Rigoni A, Tesniere A, Delahaye N, Schlemmer FD, Menger L, Sukkurwala AQ, Adjemian S, Martins I, Michaud M, Dunant A, Kepp O, Brambilla E, et al. Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer. Oncoimmunology. 1: 271-278. PMID 22737602 DOI: 10.4161/Onci.18684 |
0.735 |
|
| 2012 |
Martins I, Tesniere A, Kepp O, Michaud M, Schlemmer F, Senovilla L, Séror C, Métivier D, Perfettinic J, Zitvogel L, Kroemer G. Erratum to Martins I, et al. Cell Cycle Volume 8, Issue 22; pp. 3723–8 Cell Cycle. 11: 3901-3901. DOI: 10.4161/cc.22442 |
0.62 |
|
| 2011 |
Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, Lasarte JJ, Matsuzaki G, Ikuta K, Ryffel B, Benlagha K, et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. The Journal of Experimental Medicine. 208: 491-503. PMID 21383056 DOI: 10.1084/Jem.20100269 |
0.492 |
|
| 2011 |
Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, Lasarte JJ, Matsuzaki G, Ikuta K, Ryffel B, Benlagha K, et al. Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy The Journal of Experimental Medicine. 208: 869-869. DOI: 10.1084/Jem.201002692084C |
0.501 |
|
| 2010 |
Wemeau M, Kepp O, Tesnière A, Panaretakis T, Flament C, De Botton S, Zitvogel L, Kroemer G, Chaput N. Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia. Cell Death & Disease. 1: e104. PMID 21368877 DOI: 10.1038/Cddis.2010.82 |
0.613 |
|
| 2010 |
Martins I, Kepp O, Schlemmer F, Adjemian S, Tailler M, Shen S, Michaud M, Menger L, Gdoura A, Tajeddine N, Tesniere A, Zitvogel L, Kroemer G. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene. 30: 1147-58. PMID 21151176 DOI: 10.1038/Onc.2010.500 |
0.751 |
|
| 2010 |
Locher C, Conforti R, Aymeric L, Ma Y, Yamazaki T, Rusakiewicz S, Tesnière A, Ghiringhelli F, Apetoh L, Morel Y, Girard JP, Kroemer G, Zitvogel L. Desirable cell death during anticancer chemotherapy. Annals of the New York Academy of Sciences. 1209: 99-108. PMID 20958322 DOI: 10.1111/J.1749-6632.2010.05763.X |
0.612 |
|
| 2010 |
Kepp O, Gdoura A, Martins I, Panaretakis T, Schlemmer F, Tesniere A, Fimia GM, Ciccosanti F, Burgevin A, Piacentini M, Eggleton P, Young PJ, Zitvogel L, van Endert P, Kroemer G. Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death. Cell Cycle (Georgetown, Tex.). 9: 3072-7. PMID 20699648 DOI: 10.4161/Cc.9.15.12459 |
0.797 |
|
| 2010 |
Tesniere A, Abermil N, Schlemmer F, Casares N, Kepp O, Pequignot M, Michaud M, Martins I, Senovilla L, Zitvogel L, Kroemer G. In vivo depletion of T lymphocyte-specific transcription factors by RNA interference. Cell Cycle (Georgetown, Tex.). 9: 2830-5. PMID 20647758 DOI: 10.4161/Cc.9.14.12256 |
0.732 |
|
| 2010 |
Ma Y, Kepp O, Ghiringhelli F, Apetoh L, Aymeric L, Locher C, Tesniere A, Martins I, Ly A, Haynes NM, Smyth MJ, Kroemer G, Zitvogel L. Chemotherapy and radiotherapy: cryptic anticancer vaccines. Seminars in Immunology. 22: 113-24. PMID 20403709 DOI: 10.1016/J.Smim.2010.03.001 |
0.57 |
|
| 2010 |
Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, et al. IKK connects autophagy to major stress pathways. Autophagy. 6: 189-91. PMID 20110771 DOI: 10.4161/Auto.6.1.10818 |
0.762 |
|
| 2010 |
Aymeric L, Apetoh L, Ghiringhelli F, Tesniere A, Martins I, Kroemer G, Smyth MJ, Zitvogel L. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Research. 70: 855-8. PMID 20086177 DOI: 10.1158/0008-5472.Can-09-3566 |
0.594 |
|
| 2010 |
Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, et al. The IKK complex contributes to the induction of autophagy. The Embo Journal. 29: 619-31. PMID 19959994 DOI: 10.1038/Emboj.2009.364 |
0.769 |
|
| 2009 |
Tesniere A, Kroemer G, Tursz T, Zitvogel L. Personalized immunotherapy: a siren myth? Personalized Medicine. 6: 469-473. PMID 29783309 DOI: 10.2217/Pme.09.39 |
0.527 |
|
| 2009 |
Kepp O, Galluzzi L, Giordanetto F, Tesniere A, Vitale I, Martins I, Schlemmer F, Adjemian S, Zitvogel L, Kroemer G. Disruption of the PP1/GADD34 complex induces calreticulin exposure. Cell Cycle (Georgetown, Tex.). 8: 3971-7. PMID 19901557 DOI: 10.4161/Cc.8.23.10191 |
0.788 |
|
| 2009 |
Tesniere A, Schlemmer F, Boige V, Kepp O, Martins I, Ghiringhelli F, Aymeric L, Michaud M, Apetoh L, Barault L, Mendiboure J, Pignon JP, Jooste V, van Endert P, Ducreux M, et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene. 29: 482-91. PMID 19881547 DOI: 10.1038/Onc.2009.356 |
0.764 |
|
| 2009 |
Martins I, Tesniere A, Kepp O, Michaud M, Schlemmer F, Senovilla L, Séror C, Métivier D, Perfettini JL, Zitvogel L, Kroemer G. Chemotherapy induces ATP release from tumor cells. Cell Cycle (Georgetown, Tex.). 8: 3723-8. PMID 19855167 DOI: 10.4161/Cc.8.22.10026 |
0.765 |
|
| 2009 |
Locher C, Rusakiewicz S, Tesnière A, Ghiringhelli F, Apetoh L, Kroemer G, Zitvogel L. Witch hunt against tumor cells enhanced by dendritic cells. Annals of the New York Academy of Sciences. 1174: 51-60. PMID 19769736 DOI: 10.1111/J.1749-6632.2009.04940.X |
0.601 |
|
| 2009 |
Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini JL, Schlemmer F, Tasdemir E, Uhl M, Génin P, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1Β-dependent adaptive immunity against tumors Nature Medicine. 15: 1170-1178. PMID 19767732 DOI: 10.1038/Nm.2028 |
0.806 |
|
| 2009 |
Kepp O, Senovilla L, Galluzzi L, Panaretakis T, Tesniere A, Schlemmer F, Madeo F, Zitvogel L, Kroemer G. Viral subversion of immunogenic cell death. Cell Cycle (Georgetown, Tex.). 8: 860-9. PMID 19221507 DOI: 10.4161/Cc.8.6.7939 |
0.805 |
|
| 2009 |
Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, Durchschlag M, Joza N, Pierron G, van Endert P, Yuan J, Zitvogel L, Madeo F, Williams DB, Kroemer G. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. The Embo Journal. 28: 578-90. PMID 19165151 DOI: 10.1038/Emboj.2009.1 |
0.625 |
|
| 2009 |
Kepp O, Tesniere A, Schlemmer F, Michaud M, Senovilla L, Zitvogel L, Kroemer G. Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis : An International Journal On Programmed Cell Death. 14: 364-75. PMID 19145485 DOI: 10.1007/S10495-008-0303-9 |
0.801 |
|
| 2009 |
Kepp O, Tesniere A, Zitvogel L, Kroemer G. The immunogenicity of tumor cell death. Current Opinion in Oncology. 21: 71-6. PMID 19125021 DOI: 10.1097/Cco.0B013E32831Bc375 |
0.619 |
|
| 2008 |
Zitvogel L, Tesniere A, Apetoh L, Ghiringhelli F, Kroemer G. [Immunological aspects of anticancer chemotherapy]. Bulletin De L'Academie Nationale De Medecine. 192: 1469-87; discussion . PMID 19445369 |
0.54 |
|
| 2008 |
Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G. Immunogenic cancer cell death: a key-lock paradigm. Current Opinion in Immunology. 20: 504-11. PMID 18573340 DOI: 10.1016/J.Coi.2008.05.007 |
0.786 |
|
| 2008 |
Zitvogel L, Apetoh L, Ghiringhelli F, André F, Tesniere A, Kroemer G. The anticancer immune response: indispensable for therapeutic success? The Journal of Clinical Investigation. 118: 1991-2001. PMID 18523649 DOI: 10.1172/Jci35180 |
0.55 |
|
| 2008 |
Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L. Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Research. 68: 4026-30. PMID 18519658 DOI: 10.1158/0008-5472.Can-08-0427 |
0.618 |
|
| 2008 |
Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, Durchschlag M, Fimia GM, Kepp O, Piacentini M, Froehlich KU, van Endert P, Zitvogel L, Madeo F, Kroemer G. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death and Differentiation. 15: 1499-509. PMID 18464797 DOI: 10.1038/Cdd.2008.67 |
0.639 |
|
| 2008 |
Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Mignot G, Ullrich E, Kroemer G, Zitvogel L. Cancer is not just a disease of a tissue: it is a host disease. How to reactivate host defense against tumors using conventional therapies of cancer? Annales D'Endocrinologie. 69: 151-2. PMID 18420177 DOI: 10.1016/J.Ando.2008.02.016 |
0.424 |
|
| 2008 |
Tufi R, Panaretakis T, Bianchi K, Criollo A, Fazi B, Di Sano F, Tesniere A, Kepp O, Paterlini-Brechot P, Zitvogel L, Piacentini M, Szabadkai G, Kroemer G. Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin. Cell Death and Differentiation. 15: 274-82. PMID 18034188 DOI: 10.1038/Sj.Cdd.4402275 |
0.511 |
|
| 2008 |
Zitvogel L, Tesniere A, Apetoh L, Ghiringhelli F, Kroemer G. Contribution du système immunitaire à l’efficacité des chimiothérapies anticancéreuses Bulletin De L'AcadéMie Nationale De MéDecine. 192: 1469-1489. DOI: 10.1016/S0001-4079(19)32694-9 |
0.349 |
|
| 2008 |
Apetoh L, Ghiringhelli F, Tesniere A, Kroemer G, Zitvogel L. OR.13. Endogenous Danger Signals from Dying Tumor Cells Promote T-cell-dependent Antitumor Responses Which Determine the Efficacy of Conventional Anticancer Therapies Clinical Immunology. 127: S8. DOI: 10.1016/J.Clim.2008.03.018 |
0.555 |
|
| 2007 |
Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. Molecular characteristics of immunogenic cancer cell death. Cell Death and Differentiation. 15: 3-12. PMID 18007663 DOI: 10.1038/Sj.Cdd.4402269 |
0.645 |
|
| 2007 |
Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R, Mariette C, Chaput N, Mira JP, Delaloge S, André F, Tursz T, Kroemer G, Zitvogel L. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunological Reviews. 220: 47-59. PMID 17979839 DOI: 10.1111/J.1600-065X.2007.00573.X |
0.575 |
|
| 2007 |
Obeid M, Tesniere A, Panaretakis T, Tufi R, Joza N, van Endert P, Ghiringhelli F, Apetoh L, Chaput N, Flament C, Ullrich E, de Botton S, Zitvogel L, Kroemer G. Ecto-calreticulin in immunogenic chemotherapy. Immunological Reviews. 220: 22-34. PMID 17979837 DOI: 10.1111/J.1600-065X.2007.00567.X |
0.812 |
|
| 2007 |
Apetoh L, Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Piacentini M, Kroemer G, Zitvogel L. Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells. Cancer Genomics & Proteomics. 4: 65-70. PMID 17804868 |
0.779 |
|
| 2007 |
Obeid M, Panaretakis T, Tesniere A, Joza N, Tufi R, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic. Cancer Research. 67: 7941-4. PMID 17804698 DOI: 10.1158/0008-5472.Can-07-1622 |
0.805 |
|
| 2007 |
Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Medicine. 13: 1050-9. PMID 17704786 DOI: 10.1038/Nm1622 |
0.792 |
|
| 2007 |
Obeid M, Panaretakis T, Joza N, Tufi R, Tesniere A, van Endert P, Zitvogel L, Kroemer G. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death and Differentiation. 14: 1848-50. PMID 17657249 DOI: 10.1038/Sj.Cdd.4402201 |
0.716 |
|
| 2007 |
Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Métivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nature Medicine. 13: 54-61. PMID 17187072 DOI: 10.1038/Nm1523 |
0.816 |
|
| 2006 |
Tesniere A, Zitvogel L, Kroemer G. The immune system: taming and unleashing cancer. Discovery Medicine. 6: 211-6. PMID 17250785 |
0.442 |
|
| 2006 |
Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nature Reviews. Immunology. 6: 715-27. PMID 16977338 DOI: 10.1038/Nri1936 |
0.539 |
|
| 2005 |
Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, Schmitt E, Hamai A, Hervas-Stubbs S, Obeid M, Coutant F, Métivier D, Pichard E, Aucouturier P, Pierron G, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. The Journal of Experimental Medicine. 202: 1691-701. PMID 16365148 DOI: 10.1084/Jem.20050915 |
0.802 |
|
| Show low-probability matches. |